Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Hematological changes following low dose radiation therapy and comparison to current standard of care cancer treatments
This highlights one of the most common issues we found in the dataset
Importantly, HER-2/neu overexpression is a clinically relevant target in human breast cancers, making this model highly translational for cancer risk mitigation in susceptible populations
10.1007/s00253-011-3574-y 34 TraviesoT.LiJ.MaheshS.MelloJ
US$ 20.63
US$ 27.43
US$ 21.72
US$ 21.51
